Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-23-011269
Filing Date
2023-12-21
Accepted
2023-12-21 17:02:19
Documents
11

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 5981692
2 GRAPHIC g476668g00d20.jpg GRAPHIC 34467
3 GRAPHIC g476668g00y12.jpg GRAPHIC 26789
4 GRAPHIC g476668g00y13.jpg GRAPHIC 52296
5 GRAPHIC g476668g00y14.jpg GRAPHIC 42460
6 GRAPHIC g476668g01p01.jpg GRAPHIC 23741
7 GRAPHIC g476668g01p02.jpg GRAPHIC 30903
8 GRAPHIC g476668g01p49.jpg GRAPHIC 25573
9 GRAPHIC g476668g01p50.jpg GRAPHIC 23237
10 GRAPHIC g476668g18w60.jpg GRAPHIC 134751
11 GRAPHIC g476668g79s64.jpg GRAPHIC 48036
  Complete submission text file 0000950123-23-011269.txt   6581495
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-07014 | Film No.: 231506050
SIC: 6770 Blank Checks
(CF Office: 08 Industrial Applications and Services)